Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?
Wasiak
Jason
J
Centre for Clinical Effectiveness, Southern Health/Monash Institute of Public Health, Melbourne, VIC, Australia. Jason.Wasiak@med.monash.edu.au
Hoare
Brian J
BJ
Hender
Kim M
KM
D001132:Arm; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A